Hypersensitivity to chromium-induced DNA damage correlates with constitutive deregulation of upstream p53 kinases in p21-/- HCT116 colon cancer cells.

[1]  I. Roninson,et al.  p21 (CDKN1A) is a Negative Regulator of p53 Stability , 2007, Cell cycle.

[2]  C. Prives,et al.  p53-Dependent p21 mRNA Elongation Is Impaired when DNA Replication Is Stalled , 2006, Molecular and Cellular Biology.

[3]  Bo Xu,et al.  ATR regulates hexavalent chromium-induced S-phase checkpoint through phosphorylation of SMC1. , 2006, Mutation research.

[4]  D. Green,et al.  Cytoplasmic p53: Bax and Forward , 2004, Cell cycle.

[5]  Martin Schuler,et al.  Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis , 2004, Science.

[6]  R. Fotedar,et al.  Role of p21WAF1 in the Cellular Response to UV , 2004, Cell cycle.

[7]  S. Patierno,et al.  Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. , 2003, Mutation research.

[8]  S. Patierno,et al.  Chromium (VI) Activates Ataxia Telangiectasia Mutated (ATM) Protein , 2003, The Journal of Biological Chemistry.

[9]  D. Green,et al.  p53 triggers apoptosis in oncogene-expressing fibroblasts by the induction of Noxa and mitochondrial Bax translocation , 2003, Cell Death and Differentiation.

[10]  W. El-Deiry,et al.  Tissue-specific induction of p53 targets in vivo. , 2002, Cancer research.

[11]  S. Patierno,et al.  Effects of hexavalent chromium on the survival and cell cycle distribution of DNA repair-deficient S. cerevisiae. , 2002, DNA repair.

[12]  Ying Li,et al.  AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival* , 2002, The Journal of Biological Chemistry.

[13]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[14]  R. Iggo,et al.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[16]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[17]  K. Kinzler,et al.  Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.

[18]  K. Kinzler,et al.  Cooperative effects of genes controlling the G(2)/M checkpoint. , 2000, Genes & development.

[19]  W. El-Deiry,et al.  p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. , 2000, Biochemical and biophysical research communications.

[20]  M. Miura,et al.  Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 , 1999, Oncogene.

[21]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[22]  M. Miura,et al.  Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.

[23]  R. Bose,et al.  Mechanisms of DNA damage by chromium(V) carcinogens. , 1998, Nucleic acids research.

[24]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[25]  A. Gartel,et al.  p21—Negative Regulator of the Cell Cycle , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[26]  K. Kinzler,et al.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells. , 1995, Cancer research.

[27]  L. J. Maher,et al.  DNA bending by asymmetric phosphate neutralization. , 1994, Science.

[28]  S. Patierno,et al.  Dna polymerase arrest by adducted trivalent chromium , 1994, Molecular carcinogenesis.

[29]  A. Zhitkovich,et al.  Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells. , 1992, Carcinogenesis.

[30]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[31]  P. Elias,et al.  Human epidermal proteolipids: isolation, partial characterization, and subcellular localization. , 1988, The Journal of investigative dermatology.

[32]  S. Patierno,et al.  Transcriptional inhibition by carcinogenic chromate: Relationship to DNA damage , 1992, Molecular carcinogenesis.